Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0141395 |
| CAS No | NA |
| Mol.F. | C9H10BrClN4O |
| Mol.Wt. | 305.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141396 |
| CAS No | NA |
| Mol.F. | C12H13ClN4O2 |
| Mol.Wt. | 280.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141397 |
| CAS No | NA |
| Mol.F. | C28H37N9O4 |
| Mol.Wt. | 563.7 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141398 |
| CAS No | NA |
| Mol.F. | C27H33N9O5 |
| Mol.Wt. | 563.6 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141399 |
| CAS No | NA |
| Mol.F. | C9H13N5O |
| Mol.Wt. | 207.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141400 |
| CAS No | NA |
| Mol.F. | C16H12N4O4 |
| Mol.Wt. | 324.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141401 |
| CAS No | NA |
| Mol.F. | C17H13N3O4 |
| Mol.Wt. | 323.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141402 |
| CAS No | NA |
| Mol.F. | C14H12N2O2 |
| Mol.Wt. | 240.3 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141403 |
| CAS No | NA |
| Mol.F. | C29H20N4O3 |
| Mol.Wt. | 472.5 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141404 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141405 |
| CAS No | NA |
| Mol.F. | C23H23BrN4O4 |
| Mol.Wt. | 499.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141406 |
| CAS No | NA |
| Mol.F. | C9H7N3O4 |
| Mol.Wt. | 221.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141407 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141408 |
| CAS No | NA |
| Mol.F. | C16H13N3O4 |
| Mol.Wt. | 311.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141409 |
| CAS No | NA |
| Mol.F. | C18H18N4O3 |
| Mol.Wt. | 338.4 |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0141410 |
| CAS No | NA |
| Mol.F. | C11H12N4O3 |
| Mol.Wt. | 248.2 |
| INV STATUS | CUSTOM SYNTHESIS |